GHRL and prostate carcinoma: According to a previous study, In1-ghrelin levels (in tissue) and circulating levels (in plasma) are increased in prostate cancer to regulate key pathophysiological processes, including cell-proliferation, migration and PSA secretion (Hormaechea-Agulla et al., 2017).